dermatan sulfate has been researched along with deferoxamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Antich, P; Chen, H; Constantanescu, A; Dadey, E; Kulkarni, P; Mason, R; Parkey, R; Ranney, D; Singh, O | 1 |
1 review(s) available for dermatan sulfate and deferoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for dermatan sulfate and deferoxamine
| Article | Year |
|---|---|
Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy.
Topics: Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carbohydrate Sequence; Carbohydrates; Chemistry, Pharmaceutical; Deferoxamine; Dermatan Sulfate; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Gadolinium DTPA; Heparin; Humans; Iron Chelating Agents; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Molecular Sequence Data; Neoplasm Transplantation; Neoplasms; Prostatic Neoplasms; Rats | 2005 |